<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">36673565</PMID><DateRevised><Year>2023</Year><Month>02</Month><Day>01</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2227-9032</ISSN><JournalIssue CitedMedium="Print"><Volume>11</Volume><Issue>2</Issue><PubDate><Year>2023</Year><Month>Jan</Month><Day>09</Day></PubDate></JournalIssue><Title>Healthcare (Basel, Switzerland)</Title><ISOAbbreviation>Healthcare (Basel)</ISOAbbreviation></Journal><ArticleTitle>Clinical Characteristics in the Acute Phase of COVID-19 That Predict Long COVID: Tachycardia, Myalgias, Severity, and Use of Antibiotics as Main Risk Factors, While Education and Blood Group B Are Protective.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">197</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/healthcare11020197</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Risk factors for developing long COVID are not clearly established. The present study was designed to determine if any sign, symptom, or treatment of the acute phase, or personal characteristics of the patient, is associated with the development of long COVID.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A cohort study was carried out, randomly selecting symptomatic COVID-19 patients and not vaccinated. The severity of the acute illness was assessed through the number of compatible COVID-19 symptoms, hospitalizations, and the symptom severity score using a 10-point visual analog scale.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">After multivariate analysis, a severity score &#x2265;8 (RR 2.0, 95%CI 1.1-3.5, <i>p</i> = 0.022), hospitalization (RR 2.1, 95%CI 1.0-4.4, <i>p</i> = 0.039), myalgia (RR 1.9, 95%CI 1.08-3.6, <i>p</i> = 0.027), tachycardia (RR 10.4, 95%CI 2.2-47.7, <i>p</i> = 0.003), and use of antibiotics (RR 2.0, 95%CI 1.1-3.5, <i>p</i> = 0.022), was positively associated with the risk of having long COVID. Higher levels of education (RR 0.6, 95%CI 0.4-0.9, <i>p</i> = 0.029) and type positive B blood group (B + AB, RR 0.44, 95%CI 0.2-0.9, <i>p</i> = 0.044) were protective factors. The most important population attributable fractions (PAFs) for long COVID were myalgia (37%), severity score &#x2265;8 (31%), and use of antibiotics (27%).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Further studies in diverse populations over time are needed to expand the knowledge that could lead us to prevent and/or treat long COVID.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Guzman-Esquivel</LastName><ForeName>Jose</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>School of Medicine, University of Colima, Colima 28040, Mexico.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinical Epidemiology Research Unit, Mexican Institute of Social Security Institute, Villa de &#xc1;lvarez 28984, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mendoza-Hernandez</LastName><ForeName>Martha A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>School of Medicine, University of Colima, Colima 28040, Mexico.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinical Epidemiology Research Unit, Mexican Institute of Social Security Institute, Villa de &#xc1;lvarez 28984, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guzman-Solorzano</LastName><ForeName>Hannah P</ForeName><Initials>HP</Initials><AffiliationInfo><Affiliation>School of Medicine, University of Colima, Colima 28040, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sarmiento-Hernandez</LastName><ForeName>Karla A</ForeName><Initials>KA</Initials><AffiliationInfo><Affiliation>School of Medicine, University of Colima, Colima 28040, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rodriguez-Sanchez</LastName><ForeName>Iram P</ForeName><Initials>IP</Initials><Identifier Source="ORCID">0000-0002-5988-4168</Identifier><AffiliationInfo><Affiliation>Molecular and Structural Physiology Laboratory, School of Biological Sciences, Universidad Aut&#xf3;noma de Nuevo Le&#xf3;n, San Nicol&#xe1;s de los Garza 66455, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martinez-Fierro</LastName><ForeName>Margarita L</ForeName><Initials>ML</Initials><Identifier Source="ORCID">0000-0003-1478-9068</Identifier><AffiliationInfo><Affiliation>Molecular Medicine Laboratory, Unidad de Medicina Humana y Ciencias de la Salud, Universidad Aut&#xf3;noma de Zacatecas, Zacatecas 98160, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Paz-Michel</LastName><ForeName>Brenda A</ForeName><Initials>BA</Initials><AffiliationInfo><Affiliation>School of Medicine, University of Colima, Colima 28040, Mexico.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Research, Esteripharma SA de CV, Atlacomulco 50450, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Murillo-Zamora</LastName><ForeName>Efren</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-1118-498X</Identifier><AffiliationInfo><Affiliation>School of Medicine, University of Colima, Colima 28040, Mexico.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinical Epidemiology Research Unit, Mexican Institute of Social Security Institute, Villa de &#xc1;lvarez 28984, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rojas-Larios</LastName><ForeName>Fabian</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0003-1744-9173</Identifier><AffiliationInfo><Affiliation>School of Medicine, University of Colima, Colima 28040, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lugo-Trampe</LastName><ForeName>Angel</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Faculty of Human Medicine, Campus IV, Universidad Aut&#xf3;noma de Chiapas, Tapachula 30580, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Plata-Florenzano</LastName><ForeName>Jorge E</ForeName><Initials>JE</Initials><AffiliationInfo><Affiliation>Cancerology State Institute, Colima State Health Services, Colima 28085, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Delgado-Machuca</LastName><ForeName>Marina</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>School of Medicine, University of Colima, Colima 28040, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Delgado-Enciso</LastName><ForeName>Ivan</ForeName><Initials>I</Initials><Identifier Source="ORCID">0000-0001-9848-862X</Identifier><AffiliationInfo><Affiliation>School of Medicine, University of Colima, Colima 28040, Mexico.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Cancerology State Institute, Colima State Health Services, Colima 28085, Mexico.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>319282</GrantID><Agency>Consejo Nacional de Ciencia y Tecnolog&#xed;a</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>01</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Healthcare (Basel)</MedlineTA><NlmUniqueID>101666525</NlmUniqueID><ISSNLinking>2227-9032</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">antibiotics</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">risk factor</Keyword><Keyword MajorTopicYN="N">tachycardia</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>11</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>1</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>1</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>1</Month><Day>21</Day><Hour>1</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>1</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>1</Month><Day>22</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>1</Month><Day>9</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36673565</ArticleId><ArticleId IdType="pmc">PMC9858709</ArticleId><ArticleId IdType="doi">10.3390/healthcare11020197</ArticleId><ArticleId IdType="pii">healthcare11020197</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Cascella M., Rajnik M., Cuomo A., Dulebohn S.C., Di Napoli R. Treasure Island (FL) StatPearls Publishing; Tampa, FL, USA: 2020. Features, Evaluation and Treatment Coronavirus (COVID-19)</Citation><ArticleIdList><ArticleId IdType="pubmed">32150360</ArticleId></ArticleIdList></Reference><Reference><Citation>Caldera-Villalobos C., Garza-Veloz I., Mart&#xed;nez-Avila N., Delgado-Enciso I., Ortiz-Castro Y., Cabral-Pacheco G.A., Martinez-Fierro M.L. The Coronavirus Disease (COVID-19) Challenge in Mexico: A Critical and Forced Reflection as Individuals and Society. Front. Public Heal. 2020;8:337. doi: 10.3389/fpubh.2020.00337.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2020.00337</ArticleId><ArticleId IdType="pmc">PMC7332544</ArticleId><ArticleId IdType="pubmed">32671012</ArticleId></ArticleIdList></Reference><Reference><Citation>Delgado-Enciso I., Paz-Garcia J., Barajas-Saucedo C., Mokay-Ram&#xed;rez K., Meza-Robles C., Lopez-Flores R., Delgado-Machuca M., Murillo-Zamora E., Toscano-Velazquez J., Delgado-Enciso J., et al. Safety and Efficacy of a COVID-19 Treatment with Nebulized and/or Intravenous Neutral Electrolyzed Saline Combined with Usual Medical Care vs. Usual Medical Care Alone: A Randomized, Open-label, Controlled Trial. Exp. Ther. Med. 2021;22:915. doi: 10.3892/etm.2021.10347.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/etm.2021.10347</ArticleId><ArticleId IdType="pmc">PMC8281484</ArticleId><ArticleId IdType="pubmed">34306189</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdelhafiz A.S., Ali A., Maaly A.M., Mahgoub M.A., Ziady H.H., Sultan E.A. Predictors of Post-COVID Symptoms in Egyptian Patients: Drugs Used in COVID-19 Treatment Are Incriminated. PLoS ONE. 2022;17:e0266175. doi: 10.1371/journal.pone.0266175.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0266175</ArticleId><ArticleId IdType="pmc">PMC8970499</ArticleId><ArticleId IdType="pubmed">35358268</ArticleId></ArticleIdList></Reference><Reference><Citation>Havers F.P., Pham H., Taylor C.A., Whitaker M., Patel K., Anglin O., Kambhampati A.K., Milucky J., Zell E., Moline H.L., et al. COVID-19-Associated Hospitalizations Among Vaccinated and Unvaccinated Adults 18 Years or Older in 13 US States, January 2021 to April 2022. JAMA Intern. Med. 2022;182:1071&#x2013;1081. doi: 10.1001/jamainternmed.2022.4299.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2022.4299</ArticleId><ArticleId IdType="pmc">PMC9459904</ArticleId><ArticleId IdType="pubmed">36074486</ArticleId></ArticleIdList></Reference><Reference><Citation>Baqui P., Bica I., Marra V., Ercole A., van der Schaar M. Ethnic and Regional Variations in Hospital Mortality from COVID-19 in Brazil: A Cross-Sectional Observational Study. Lancet Glob. Heal. 2020;8:e1018&#x2013;e1026. doi: 10.1016/S2214-109X(20)30285-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2214-109X(20)30285-0</ArticleId><ArticleId IdType="pmc">PMC7332269</ArticleId><ArticleId IdType="pubmed">32622400</ArticleId></ArticleIdList></Reference><Reference><Citation>Askari H., Sanadgol N., Azarnezhad A., Tajbakhsh A., Rafiei H., Safarpour A.R., Gheibihayat S.M., Raeis-Abdollahi E., Savardashtaki A., Ghanbariasad A., et al. Kidney Diseases and COVID-19 Infection: Causes and Effect, Supportive Therapeutics and Nutritional Perspectives. Heliyon. 2021;7:e06008. doi: 10.1016/j.heliyon.2021.e06008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.heliyon.2021.e06008</ArticleId><ArticleId IdType="pmc">PMC7817396</ArticleId><ArticleId IdType="pubmed">33495739</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang L.-L., Tseng C.-H., Ho H.J., Wu C.-Y. COVID-19 Mortality Is Negatively Associated with Test Number and Government Effectiveness. Sci. Rep. 2020;10:12567. doi: 10.1038/s41598-020-68862-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-68862-x</ArticleId><ArticleId IdType="pmc">PMC7381657</ArticleId><ArticleId IdType="pubmed">32709854</ArticleId></ArticleIdList></Reference><Reference><Citation>Tenforde M.W., Kim S.S., Lindsell C.J., Billig Rose E., Shapiro N.I., Files D.C., Gibbs K.W., Erickson H.L., Steingrub J.S., Smithline H.A., et al. Symptom Duration and Risk Factors for Delayed Return to Usual Health Among Outpatients with COVID-19 in a Multistate Health Care Systems Network&#x2014;United States, March&#x2013;June 2020. MMWR. Morb. Mortal. Wkly. Rep. 2020;69:993&#x2013;998. doi: 10.15585/mmwr.mm6930e1.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6930e1</ArticleId><ArticleId IdType="pmc">PMC7392393</ArticleId><ArticleId IdType="pubmed">32730238</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C., Haupert S.R., Zimmermann L., Shi X., Fritsche L.G., Mukherjee B. Global Prevalence of Post COVID-19 Condition or Long COVID: A Meta-Analysis and Systematic Review. J. Infect. Dis. 2022;226:1593&#x2013;1607. doi: 10.1093/infdis/jiac136.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiac136</ArticleId><ArticleId IdType="pmc">PMC9047189</ArticleId><ArticleId IdType="pubmed">35429399</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S., Wegman-Ostrosky T., Perelman C., Sepulveda R., Rebolledo P.A., Cuapio A., Villapol S. More than 50 Long-Term Effects of COVID-19: A Systematic Review and Meta-Analysis. Sci. Rep. 2021;11:16144. doi: 10.1038/s41598-021-95565-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-95565-8</ArticleId><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong-Chew R.M., Rodr&#xed;guez Cabrera E.X., Rodr&#xed;guez Valdez C.A., Lomelin-Gascon J., Morales-Ju&#xe1;rez L., de la Cerda M.L.R., Villa-Romero A.R., Arce Fern&#xe1;ndez S., Serratos Fernandez M., Bello H.H., et al. Symptom Cluster Analysis of Long COVID-19 in Patients Discharged from the Temporary COVID-19 Hospital in Mexico City. Ther. Adv. Infect. Dis. 2022;9:20499361211069264. doi: 10.1177/20499361211069264.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/20499361211069264</ArticleId><ArticleId IdType="pmc">PMC8764618</ArticleId><ArticleId IdType="pubmed">35059196</ArticleId></ArticleIdList></Reference><Reference><Citation>Asadi-Pooya A.A., Akbari A., Emami A., Lotfi M., Rostamihosseinkhani M., Nemati H., Barzegar Z., Kabiri M., Zeraatpisheh Z., Farjoud-Kouhanjani M., et al. Risk Factors Associated with Long COVID Syndrome: A Retrospective Study. Iran. J. Med. Sci. 2021;46:428&#x2013;436. doi: 10.30476/ijms.2021.92080.2326.</Citation><ArticleIdList><ArticleId IdType="doi">10.30476/ijms.2021.92080.2326</ArticleId><ArticleId IdType="pmc">PMC8611223</ArticleId><ArticleId IdType="pubmed">34840383</ArticleId></ArticleIdList></Reference><Reference><Citation>Crook H., Raza S., Nowell J., Young M., Edison P. Long Covid-Mechanisms, Risk Factors, and Management. BMJ. 2021;374:n1648. doi: 10.1136/bmj.n1648.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n1648</ArticleId><ArticleId IdType="pubmed">34312178</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramanian A., Nirantharakumar K., Hughes S., Myles P., Williams T., Gokhale K.M., Taverner T., Chandan J.S., Brown K., Simms-Williams N., et al. Symptoms and Risk Factors for Long COVID in Non-Hospitalized Adults. Nat. Med. 2022;28:1706&#x2013;1714. doi: 10.1038/s41591-022-01909-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01909-w</ArticleId><ArticleId IdType="pmc">PMC9388369</ArticleId><ArticleId IdType="pubmed">35879616</ArticleId></ArticleIdList></Reference><Reference><Citation>Rana R, Ranjan V and Kumar N: Association of ABO and Rh Blood Group in Susceptibility, Severity, and Mortality of Coronavirus Disease 2019: A Hospital-Based Study from Delhi, India. Front. Cell. Infect. Microbiol. 2021;11:767771. doi: 10.3389/fcimb.2021.767771.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2021.767771</ArticleId><ArticleId IdType="pmc">PMC8593001</ArticleId><ArticleId IdType="pubmed">34796130</ArticleId></ArticleIdList></Reference><Reference><Citation>Rivett L., Sridhar S., Sparkes D., Routledge M., Jones N.K., Forrest S., Young J., Pereira-Dias J., Hamilton W.L., Ferris M., et al. Screening of Healthcare Workers for SARS-CoV-2 Highlights the Role of Asymptomatic Carriage in COVID-19 Transmission. eLife. 2020;9:e58728. doi: 10.7554/eLife.58728.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.58728</ArticleId><ArticleId IdType="pmc">PMC7314537</ArticleId><ArticleId IdType="pubmed">32392129</ArticleId></ArticleIdList></Reference><Reference><Citation>Fors M., Gonz&#xe1;lez P., Viada C., Falcon K., Palacios S. Validity of the Fitzpatrick Skin Phototype Classification in Ecuador. Adv. Skin Wound Care. 2020;33:1&#x2013;5. doi: 10.1097/01.ASW.0000721168.40561.a3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.ASW.0000721168.40561.a3</ArticleId><ArticleId IdType="pmc">PMC7678657</ArticleId><ArticleId IdType="pubmed">33208633</ArticleId></ArticleIdList></Reference><Reference><Citation>Skipper C.P., Pastick K.A., Engen N.W., Bangdiwala A.S., Abassi M., Lofgren S.M., Williams D.A., Okafor E.C., Pullen M.F., Nicol M.R., et al. Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19. Ann. Intern. Med. 2020;173:623&#x2013;631. doi: 10.7326/M20-4207.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M20-4207</ArticleId><ArticleId IdType="pmc">PMC7384270</ArticleId><ArticleId IdType="pubmed">32673060</ArticleId></ArticleIdList></Reference><Reference><Citation>McNutt L.-A., Wu C., Xue X., Hafner J.P. Estimating the Relative Risk in Cohort Studies and Clinical Trials of Common Outcomes. Am. J. Epidemiol. 2003;157:940&#x2013;943. doi: 10.1093/aje/kwg074.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/aje/kwg074</ArticleId><ArticleId IdType="pubmed">12746247</ArticleId></ArticleIdList></Reference><Reference><Citation>Wacholder S. Binomial Regression in GLIM: Estimating Risk Ratios and Risk Differences. Am. J. Epidemiol. 1986;123:174&#x2013;184. doi: 10.1093/oxfordjournals.aje.a114212.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/oxfordjournals.aje.a114212</ArticleId><ArticleId IdType="pubmed">3509965</ArticleId></ArticleIdList></Reference><Reference><Citation>Diaz-Quijano F.A. A Simple Method for Estimating Relative Risk Using Logistic Regression. BMC Med. Res. Methodol. 2012;12:14. doi: 10.1186/1471-2288-12-14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2288-12-14</ArticleId><ArticleId IdType="pmc">PMC3305608</ArticleId><ArticleId IdType="pubmed">22335836</ArticleId></ArticleIdList></Reference><Reference><Citation>Mansournia M.A., Altman D.G. Population Attributable Fraction. BMJ. 2018;360:k757. doi: 10.1136/bmj.k757.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.k757</ArticleId><ArticleId IdType="pubmed">29472187</ArticleId></ArticleIdList></Reference><Reference><Citation>Bernard R. Fundamentals of Biostatistics. 5th ed. PWS Publishing; Boston, MA, USA: 2000.</Citation></Reference><Reference><Citation>Pewsner D., Battaglia M., Minder C., Marx A., Bucher H.C., Egger M. Ruling a Diagnosis in or out with &#x201c;SpPIn&#x201d; and &#x201c;SnNOut&#x201d;: A Note of Caution. BMJ. 2004;329:209&#x2013;213. doi: 10.1136/bmj.329.7459.209.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.329.7459.209</ArticleId><ArticleId IdType="pmc">PMC487735</ArticleId><ArticleId IdType="pubmed">15271832</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen N., Zhou M., Dong X., Qu J., Gong F., Han Y., Qiu Y., Wang J., Liu Y., Wei Y., et al. Epidemiological and Clinical Characteristics of 99 Cases of 2019 Novel Coronavirus Pneumonia in Wuhan, China: A Descriptive Study. Lancet. 2020;395:507&#x2013;513. doi: 10.1016/S0140-6736(20)30211-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30211-7</ArticleId><ArticleId IdType="pmc">PMC7135076</ArticleId><ArticleId IdType="pubmed">32007143</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsieh J.Y.C., Kan J.Y.L., Mattar S.A.M., Qin Y. The Clinical Implications of Sinus Tachycardia in Mild COVID-19 Infection: A Retrospective Cohort Study. SAGE Open Med. 2021;9:20503121211054972. doi: 10.1177/20503121211054973.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/20503121211054973</ArticleId><ArticleId IdType="pmc">PMC8559187</ArticleId><ArticleId IdType="pubmed">34733514</ArticleId></ArticleIdList></Reference><Reference><Citation>Denegri A., Sola M., Morelli M., Farioli F., Alberto T., D&#x2019;Arienzo M., Savorani F., Pezzuto G.S., Boriani G., Szarpak L., et al. Arrhythmias in COVID-19/SARS-CoV-2 Pneumonia Infection: Prevalence and Implication for Outcomes. J. Clin. Med. 2022;11:1463. doi: 10.3390/jcm11051463.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11051463</ArticleId><ArticleId IdType="pmc">PMC8911084</ArticleId><ArticleId IdType="pubmed">35268554</ArticleId></ArticleIdList></Reference><Reference><Citation>Arany&#xf3; J., Bazan V., Llad&#xf3;s G., Dominguez M.J., Bisbal F., Massanella M., Sarrias A., Adeli&#xf1;o R., Riverola A., Paredes R., et al. Inappropriate Sinus Tachycardia in Post-COVID-19 Syndrome. Sci. Rep. 2022;12:298. doi: 10.1038/s41598-021-03831-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-03831-6</ArticleId><ArticleId IdType="pmc">PMC8741896</ArticleId><ArticleId IdType="pubmed">34996973</ArticleId></ArticleIdList></Reference><Reference><Citation>Kucuk A., Cumhur Cure M., Cure E. Can COVID-19 Cause Myalgia with a Completely Different Mechanism? A Hypothesis. Clin. Rheumatol. 2020;39:2103&#x2013;2104. doi: 10.1007/s10067-020-05178-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10067-020-05178-1</ArticleId><ArticleId IdType="pmc">PMC7249985</ArticleId><ArticleId IdType="pubmed">32458242</ArticleId></ArticleIdList></Reference><Reference><Citation>Queme L.F., Ross J.L., Jankowski M.P. Peripheral Mechanisms of Ischemic Myalgia. Front. Cell. Neurosci. 2017;11:419. doi: 10.3389/fncel.2017.00419.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2017.00419</ArticleId><ArticleId IdType="pmc">PMC5743676</ArticleId><ArticleId IdType="pubmed">29311839</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Q., Mak J.W.Y., Su Q., Yeoh Y.K., Lui G.C.-Y., Ng S.S.S., Zhang F., Li A.Y.L., Lu W., Hui D.S.-C., et al. Gut Microbiota Dynamics in a Prospective Cohort of Patients with Post-Acute COVID-19 Syndrome. Gut. 2022;71:544&#x2013;552. doi: 10.1136/gutjnl-2021-325989.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2021-325989</ArticleId><ArticleId IdType="pubmed">35082169</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen Q.V., Chong L.C., Hor Y.-Y., Lew L.-C., Rather I.A., Choi S.-B. Role of Probiotics in the Management of COVID-19: A Computational Perspective. Nutrients. 2022;14:274. doi: 10.3390/nu14020274.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu14020274</ArticleId><ArticleId IdType="pmc">PMC8781206</ArticleId><ArticleId IdType="pubmed">35057455</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly Z., Bowe B., Xie Y. Long COVID after breakthrough SARS-CoV-2 infection. Nat. Med. 2022;28:1461&#x2013;1467. doi: 10.1038/s41591-022-01840-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01840-0</ArticleId><ArticleId IdType="pmc">PMC9307472</ArticleId><ArticleId IdType="pubmed">35614233</ArticleId></ArticleIdList></Reference><Reference><Citation>Notarte K.I., Catahay J.A., Velasco J.V., Pastrana A., Ver A.T., Pangilinan F.C., Peligro P.J., Casimiro M., Guerrero J.J., Gellaco M.M.L., et al. Impact of COVID-19 Vaccination on the Risk of Developing Long-COVID and on Existing Long-COVID Symptoms: A Systematic Review. EClinicalMedicine. 2022;53:101624. doi: 10.1016/j.eclinm.2022.101624.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2022.101624</ArticleId><ArticleId IdType="pmc">PMC9417563</ArticleId><ArticleId IdType="pubmed">36051247</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim Y., Latz C.A., DeCarlo C.S., Lee S., Png C.Y.M., Kibrik P., Sung E., Alabi O., Dua A. Relationship between Blood Type and Outcomes Following COVID-19 Infection. Semin. Vasc. Surg. 2021;34:125&#x2013;131. doi: 10.1053/j.semvascsurg.2021.05.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.semvascsurg.2021.05.005</ArticleId><ArticleId IdType="pmc">PMC8286549</ArticleId><ArticleId IdType="pubmed">34642032</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#xed;az-Salazar S., Navas R., Sainz-Maza L., Fierro P., Maamar M., Artime A., Basterrechea H., Petitta B., Pini S., Olmos J.M., et al. Blood Group O Is Associated with Post-COVID-19 Syndrome in Outpatients with a Low Comorbidity Index. Infect. Dis. 2022;54:897&#x2013;908. doi: 10.1080/23744235.2022.2115548.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/23744235.2022.2115548</ArticleId><ArticleId IdType="pubmed">36036090</ArticleId></ArticleIdList></Reference><Reference><Citation>Latz C.A., DeCarlo C., Boitano L., Png C.Y.M., Patell R., Conrad M.F., Eagleton M., Dua A. Blood Type and Outcomes in Patients with COVID-19. Ann. Hematol. 2020;99:2113&#x2013;2118. doi: 10.1007/s00277-020-04169-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00277-020-04169-1</ArticleId><ArticleId IdType="pmc">PMC7354354</ArticleId><ArticleId IdType="pubmed">32656591</ArticleId></ArticleIdList></Reference><Reference><Citation>Moslemi C., Saekmose S., Larsen R., Brodersen T., Didriksen M., Hjalgrim H., Banasik K., Nielsen K.R., Bruun M.T., Dowsett J., et al. A Large Cohort Study of the Effects of Lewis, ABO, 13 Other Blood Groups and Secretor Status on COVID-19 Susceptibility, Severity, and Long COVID-19. Transfusion. 2023;63:1&#x2013;12. doi: 10.1111/trf.17170.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/trf.17170</ArticleId><ArticleId IdType="pmc">PMC9874484</ArticleId><ArticleId IdType="pubmed">36271437</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Y., Yuan D., Chen D.G., Ng R.H., Wang K., Choi J., Li S., Hong S., Zhang R., Xie J., et al. Multiple Early Factors Anticipate Post-Acute COVID-19 Sequelae. Cell. 2022;185:881&#x2013;895.e20. doi: 10.1016/j.cell.2022.01.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.01.014</ArticleId><ArticleId IdType="pmc">PMC8786632</ArticleId><ArticleId IdType="pubmed">35216672</ArticleId></ArticleIdList></Reference><Reference><Citation>Bagheri Lankarani K., Honarvar B., Omidifar N., Pakdin M., Moghadami M., Shokripour M., Dorraninejad S.A., Samadi K., Chashmpoosh M., Pourataei F., et al. Prevalence of Anti-SARS-CoV-2 Antibody in Hospital Staff in Double-Center Setting: A Preliminary Report of a Cohort Study From Iran. Shiraz E-Med. J. 2021;22:e112681. doi: 10.5812/semj.112681.</Citation><ArticleIdList><ArticleId IdType="doi">10.5812/semj.112681</ArticleId></ArticleIdList></Reference><Reference><Citation>Amanat A., Bagheri Lankarani K., Honarvar B., Asmarian N., Shokripour M., Rafiee F., Aghazadeh M.B., Izadi F., Omidifar N., Dorraninejad S.A. SARS-CoV-2 Antibodies in the Public Hospital Staff: The Second Report of a Seroprevalence Cohort Study from Iran. Shiraz E-Med. J. 2022;23:e121681. doi: 10.5812/semj-121681.</Citation><ArticleIdList><ArticleId IdType="doi">10.5812/semj-121681</ArticleId></ArticleIdList></Reference><Reference><Citation>P&#x103;unescu R.L., Miclu Ia I.V., Veri&#x15f;ezan O.R., Crecan-Suciu B.D. Acute and Long-term Psychiatric Symptoms Associated with COVID-19 (Review) Biomed. Rep. 2023;18:4. doi: 10.3892/br.2022.1586.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/br.2022.1586</ArticleId><ArticleId IdType="pmc">PMC9756282</ArticleId><ArticleId IdType="pubmed">36544852</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>